Sort by
Refine Your Search
-
to expand their scientific expertise while contributing to meaningful discoveries in vision science. What You’ll Bring Required Qualifications PhD or MD/PhD in a relevant scientific discipline. Strong
-
. The successful applicant will possess a PhD or equivalent doctoral degree in the social sciences, including political science, public policy, political ecology, law, geography or another relevant field with some
-
motivated individual with experience in deep learning and a PhD in computer science, electrical engineering, biomedical engineering, biomedical informatics, biostatistics or a related discipline. Required
-
Degree Requirements: The position requires expertise and PhD in molecular biology, cell biology, mouse models, and quantitative data analysis. Other Credential/Experiential Requirements: Experience in
-
. The candidate will be expected to work in a team setting with other research staff and PhD students supporting the Project HOPE 1000 pregnancy cohort. The candidate will be expected to conduct independent
-
degree (PhD or equivalent) in Statistics or Biostatistics. Solid training in statistical methods. Experience analyzing clinical trial data. Excellent written and verbal communication skills. Strong
-
-edge technologies, including genetically engineered mouse models, patient-derived models, single-cell and spatial genomics, organoid systems, and preclinical therapeutic studies. Learn more about our
-
, presentations at local/national conferences, manuscripts, and grant-related materials, depending on experience and interest. Choose Duke. Required Qualifications · PhD, MD, DO, PharmD, DVM, or equivalent doctoral
-
. or equivalent doctorate (e.g. Sc.D., M.D., D.V.M.) Preferred Qualifications:. A PhD or MD/PhD (or equivalent) in biological sciences Strong research background in cell biology, molecular biology, mouse models
-
-epithelial interactions. The role employs a multi-modal research approach spanning genetically engineered mouse models, histopathology, mouse and human organoids, CRISPR-Cas9 gene editing, single-cell